Clinical Trial Update: Low Dose IL-2 Therapy in Patients With a Depressive Episode in the Course of a Bipolar Disorder [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating low-dose interleukin-2 therapy in Bipolar Depression has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Depression

Drugs mentioned

• Low Dose IL-2 Therapy (Interleukin-2)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Bipolar Depression | Phase 2 | Status: COMPLETED